Skip to content

Danis Pharma

Active
Public limited companyfounded 1999active for 27 yearsDanislaan 13, 1650 Beersel, BelgiumKBO/BCE: BE 0465.345.721
Summary

Danis Pharma has been active since 1999 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €784,088 and a net result of €71,707. Equity is growing by about 15% per year across the filed financial years. Its solvency ranks better than 95% of 12,519 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Financials · financial year 2025, abbreviated format

Equity
€784,088▲ 10.1%
2024 · €712,381
Total assets
€866,100▲ 5.7%
2024 · €819,478
Net result
€71,707▼ 12.9%
2024 · €82,319
Working capital
€677,322▲ 12.7%
2024 · €601,051
Trend over the years

2021 to 2025, 5 financial years 2019 to 2025, 7 financial years

The operating result falls in 2025; 2025 is 14% below 2024 and is the lowest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€89,531 2025 Net result€71,707 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line2019202020212022202320242025
Operating result-€21,703-€94,268€138,365▲ 46.8%€144,132▲ 4.2%€101,234▼ 29.8%€104,459▲ 3.2%€89,531▼ 14.3%
Net result-€31,065-€71,557within the sector's middle half€97,498within the sector's middle half▲ 36.3%€100,954within the sector's middle half▲ 3.5%€73,067within the sector's middle half▼ 27.6%€82,319within the sector's middle half▲ 12.7%€71,707within the sector's middle half▼ 12.9%
Equity€286,987-€358,543within the sector's middle half▲ 24.9%€456,041within the sector's middle half▲ 27.2%€556,995within the sector's middle half▲ 22.1%€630,062within the sector's middle half▲ 13.1%€712,381within the sector's middle half▲ 13.1%€784,088above the sector's middle half▲ 10.1%
Total assets€432,332-€532,743within the sector's middle half▲ 23.2%€643,280within the sector's middle half▲ 20.7%€769,992within the sector's middle half▲ 19.7%€742,812within the sector's middle half▼ 3.5%€819,478within the sector's middle half▲ 10.3%€866,100within the sector's middle half▲ 5.7%
Debt€145,345-€174,200▲ 19.9%€187,239▲ 7.5%€212,997▲ 13.8%€112,750▼ 47.1%€107,096▼ 5.0%€82,012▼ 23.4%
Working capital€204,542-€299,081within the sector's middle half▲ 46.2%€414,762within the sector's middle half▲ 38.7%€531,760above the sector's middle half▲ 28.2%€515,861above the sector's middle half▼ 3.0%€601,051above the sector's middle half▲ 16.5%€677,322above the sector's middle half▲ 12.7%
Solvency66.4%-67.3%above the sector's middle half▲ 0.9pp70.9%above the sector's middle half▲ 3.6pp72.3%above the sector's middle half▲ 1.4pp84.8%above the sector's middle half▲ 12.5pp86.9%above the sector's middle half▲ 2.1pp90.5%above the sector's middle half▲ 3.6pp
Current ratio3.86-3.94above the sector's middle half▲ 0.074.60above the sector's middle half▲ 0.664.94above the sector's middle half▲ 0.345.82above the sector's middle half▲ 0.876.96above the sector's middle half▲ 1.149.88above the sector's middle half▲ 2.93
Return on assets (ROA)-7.2%-13.4%above the sector's middle half▲ 20.6pp15.2%above the sector's middle half▲ 1.7pp13.1%above the sector's middle half▼ 2.0pp9.8%within the sector's middle half▼ 3.3pp10.0%within the sector's middle half▲ 0.2pp8.3%within the sector's middle half▼ 1.8pp
above within below the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the abbreviated format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €866,100
Fixed assets €112,541 ▼ 4.2%
Current assets €753,559 ▲ 7.3%
Equity and liabilities €866,100
Equity €784,088 ▲ 10.1%
Debt €82,012 ▼ 23.4%
Debt's share of the balance-sheet total falls from 13.1% to 9.5%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€104,453▼
2024 · €117,496
Cash flow
€86,629▼
2024 · €95,357
Quick ratio
8.18▲
2024 · 5.57
Debt to equity
0.10▼
2024 · 0.15
ROE
9.1%▼
2024 · 11.6%
Interest coverage
11.54▼
2024 · 19.78
Debt ≤ 1 year
€76,237▼
2024 · €100,913
Income taxes
€26,460▼
2024 · €29,601
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 20,139 companies that looked in July 2024 the way this one looks now, 0.2% went bankrupt within 24 months and 95.0% are still going.

  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.2% went bankrupt
4.7% stopped otherwise
95.0% still going

For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,472 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 20,139 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 51 lines
Balance sheet Code20242025
Assets
Total assets20/58€819,478€866,100▲
Fixed assets21/28€117,513€112,541▼
Tangible fixed assets22/27€117,513€112,541▼
Land and buildings22€103,436€104,974▲
Plant, machinery and equipment23€14,077€7,567▼
Current assets29/58€701,964€753,559▲
Stocks and contracts in progress3€139,863€130,257▼
Stocks30/36€139,863€130,257▼
Amounts receivable within one year40/41€48,550€65,444▲
Trade receivables40€25,831€23,064▼
Other amounts receivable41€22,719€42,380▲
Current investments50/53€364,768€482,407▲
Cash at bank and in hand54/58€143,690€69,907▼
Deferred charges and accrued income490/1€5,094€5,544▲
Equity and liabilities
Total equity and liabilities10/49€819,478€866,100▲
Equity10/15€712,381€784,088▲
Contributions10/11€61,973€61,973=
Capital10€61,973€61,973=
Issued capital100€61,973€61,973=
Reserves13€646,197€716,197▲
Non-distributable reserves130/1€6,197€6,197=
Legal reserve130€6,197€6,197=
Distributable reserves133€640,000€710,000▲
Profit (loss) carried forward14€4,211€5,918▲
Amounts payable17/49€107,096€82,012▼
Amounts payable within one year42/48€100,913€76,237▼
Trade debts44€49,583€37,175▼
Suppliers440/4€49,583€37,175▼
Advances received on contracts in progress46€1,980-
Taxes, remuneration and social security45€1,019-
Taxes450/3€1,019-
Other amounts payable47/48€48,331€39,062▼
Accrued charges and deferred income492/3€6,183€5,775▼
Income statement Code20242025
Non-recurring operating income76A-€11,153
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€13,037€14,922▲
Other operating charges640/8€7,141€9,194▲
Gross operating margin9900€124,638€113,647▼
Operating profit (loss)9901€104,459€89,531▼
Financial income75/76B€13,402€17,686▲
Recurring financial income75€11,673€17,686▲
Non-recurring financial income76B€1,730-
Financial charges65/66B€5,941€9,050▲
Recurring financial charges65€5,941€9,050▲
Profit (loss) for the period before taxes9903€111,921€98,167▼
Income taxes67/77€29,601€26,460▼
Profit (loss) for the period9904€82,319€71,707▼
Profit (loss) for the period to be appropriated9905€82,319€71,707▼
Appropriation of the result
Profit (loss) to be appropriated9906€84,211€75,918▼
Profit (loss) brought forward from the previous period14P€1,891€4,211▲
Transfer to equity691/2€80,000€70,000▼
To other reserves6921€80,000€70,000▼

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2019202020212022202320242025Change
Non-recurring operating income76A------€11,153-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€44,052€24,563€18,478€9,905€10,070€13,037€14,922▲ 14.5%
Other operating charges640/8---€4,956€6,355€7,141€9,194▲ 28.7%
Non-recurring operating charges66A----€582---
Gross operating margin9900€26,622€122,536€162,510€158,993€118,241€124,638€113,647▼ 8.8%
Operating profit (loss)9901-€21,703€94,268€138,365€144,132€101,234€104,459€89,531▼ 14.3%
Financial income75/76B---€432€1,871€13,402€17,686▲ 32.0%
Recurring financial income75€479€2,302€510€432€1,871€11,673€17,686▲ 51.5%
Non-recurring financial income76B-----€1,730--
Financial charges65/66B---€8,855€5,683€5,941€9,050▲ 52.3%
Recurring financial charges65€7,613€5,877€8,042€8,855€5,683€5,941€9,050▲ 52.3%
Profit (loss) for the period before taxes9903-€28,766€90,693€130,983€135,709€97,421€111,921€98,167▼ 12.3%
Income taxes67/77€2,300€19,137€33,485€34,755€24,354€29,601€26,460▼ 10.6%
Profit (loss) for the period9904-€31,065€71,557€97,498€100,954€73,067€82,319€71,707▼ 12.9%
Profit (loss) for the period to be appropriated9905-€31,065€71,557€97,498€100,954€73,067€82,319€71,707▼ 12.9%
Line2019202020212022202320242025Change
Assets
Total assets20/58€432,332€532,743€643,280€769,992€742,812€819,478€866,100▲ 5.7%
Fixed assets21/28€156,324€131,761€113,283€103,378€119,868€117,513€112,541▼ 4.2%
Tangible fixed assets22/27€156,324€131,761€113,283€103,378€119,868€117,513€112,541▼ 4.2%
Land and buildings22---€91,102€110,845€103,436€104,974▲ 1.5%
Plant, machinery and equipment23---€12,276€9,023€14,077€7,567▼ 46.2%
Current assets29/58€276,008€400,982€529,997€666,613€622,945€701,964€753,559▲ 7.3%
Stocks and contracts in progress3€128,671€141,849€141,469€142,032€136,329€139,863€130,257▼ 6.9%
Stocks30/36---€142,032€136,329€139,863€130,257▼ 6.9%
Amounts receivable within one year40/41€22,394€19,674€31,228€83,779€58,426€48,550€65,444▲ 34.8%
Trade receivables40---€57,478€27,397€25,831€23,064▼ 10.7%
Other amounts receivable41---€26,301€31,029€22,719€42,380▲ 86.5%
Current investments50/53€20,400€51,950€51,950€31,557€282,162€364,768€482,407▲ 32.3%
Cash at bank and in hand54/58€102,594€186,547€304,293€405,980€141,703€143,690€69,907▼ 51.3%
Deferred charges and accrued income490/1---€3,264€4,325€5,094€5,544▲ 8.8%
Equity and liabilities
Total equity and liabilities10/49€432,332€532,743€643,280€769,992€742,812€819,478€866,100▲ 5.7%
Equity10/15€286,987€358,543€456,041€556,995€630,062€712,381€784,088▲ 10.1%
Contributions10/11€61,973€61,973€61,973€61,973€61,973€61,973€61,973=
Capital10---€61,973€61,973€61,973€61,973=
Issued capital100---€61,973€61,973€61,973€61,973=
Reserves13€20,556€20,556€20,556€491,197€566,197€646,197€716,197▲ 10.8%
Non-distributable reserves130/1---€6,197€6,197€6,197€6,197=
Legal reserve130---€6,197€6,197€6,197€6,197=
Distributable reserves133---€485,000€560,000€640,000€710,000▲ 10.9%
Profit (loss) carried forward14€204,457€276,014€373,511€3,824€1,891€4,211€5,918▲ 40.5%
Amounts payable17/49€145,345€174,200€187,239€212,997€112,750€107,096€82,012▼ 23.4%
Amounts payable after more than one year17€69,330€69,330€69,330€69,330----
Financial debts170/4---€69,330----
Amounts payable within one year42/48€71,466€101,901€115,235€134,853€107,084€100,913€76,237▼ 24.5%
Trade debts44€35,928€31,755€42,426€74,349€52,395€49,583€37,175▼ 25.0%
Suppliers440/4---€74,349€52,395€49,583€37,175▼ 25.0%
Advances received on contracts in progress46-----€1,980--
Taxes, remuneration and social security45---€2,729€6,588€1,019--
Taxes450/3---€12€3,820€1,019--
Remuneration and social security454/9---€2,717€2,768---
Other amounts payable47/48---€57,775€48,100€48,331€39,062▼ 19.2%
Accrued charges and deferred income492/3---€8,813€5,666€6,183€5,775▼ 6.6%
Line2019202020212022202320242025Change
Profit (loss) for the period9904-€31,065€71,557€97,498€100,954€73,067€82,319€71,707▼ 12.9%
+ Depreciation and write-downs630€44,052€24,563€18,478€9,905€10,070€13,037€14,922▲ 14.5%
Operating cash flow (approximation)€12,987€96,120€115,975€110,859€83,138€95,357€86,629▼ 9.2%
Investment in fixed assets (approximation)-€0€0€0-€26,560-€10,683-€9,950▲ 6.9%
Change in cash-€83,954€117,746€101,687-€264,277€1,987-€73,783-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Latest 10 of 26 filings with the National Bank
Financial year Type Filed Reference
30-06-2025 abbreviated format 29-01-2026 2026-00034124
30-06-2024 abbreviated format 21-02-2025 2025-00037985
30-06-2023 abbreviated format 30-01-2024 2024-00021437
30-06-2022 abbreviated format 30-01-2023 2023-00021235
30-06-2021 abbreviated format 21-12-2021 2021-81600112
30-06-2020 abbreviated format 29-01-2021 2021-03400205
30-06-2019 abbreviated format 21-01-2020 2020-01800323
30-06-2018 abbreviated format 18-01-2019 2019-01800047
30-06-2017 abbreviated format 02-01-2018 2018-00100443
30-06-2016 abbreviated format 12-12-2016 2016-69800290

Show all 26 filings

Similar companies · same sector, comparable size

Of the 5,206 active companies whose main activity is retail sale of pharmaceutical products (NACE 47730), figures are known for 3,875. 3,164 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.